Careers  |  Sign In  |  Register

Biosimilar Use in the Treatment of NSCLC

In this panel discussion excerpt, Adam M. Brufsky, MD, PhD, of the University of Pittsburgh and Kashyap Patel, MD, of Carolina Blood and Cancer Care, discuss the role biosimilars can play in reducing costs while maintaining quality of care in patients with cancer, using metastatic lung cancer as a hypothetical example.

Read the full discussion transcript by clicking here.